EUVIMEDEUVIMED entdecken
Open Access

Blood steroid hormone profile and clinical outcomes following switching from metyrapone to osilodrostat in patients with Cushing disease

Kei Yokozeki, Hiraku Kameda, Aika Miya, Shigeki Jin, Kotaro Matoba, Akinobu Nakamura, Tatsuya Atsumi

Endocrine Journal · 2025

DOI: 10.1507/endocrj.ej25-0089 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Endocrine Journal, 2025. Verfasst von Kei Yokozeki und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rheumatology, Endocrinology and Nephrology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Hokkaido 060-8638…. Hauptthemen laut MEDLINE: Metyrapone, Pituitary ACTH Hypersecretion, Cortodoxone. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MetyraponePituitary ACTH HypersecretionCortodoxoneHumansMaleFemaleAdultMiddle AgedTreatment OutcomeHydrocortisoneImidazolesPyridines

Stichwörter der Autor:innen

CYP17A1Cushing diseaseMasculinizationMetyraponeOsilodrostat

Substanzen

MetyraponeOsilodrostatCortodoxoneHydrocortisoneImidazolesPyridines

Autor:innen und Institutionen

  • Department of Rheumatology, Endocrinology and Nephrology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Hokkaido 060-8638, Japan.
  • Department of Forensic Medicine, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Hokkaido 060-8638, Japan.

Zitieren

APA

Yokozeki, K., Kameda, H., Miya, A., Jin, S., Matoba, K., Nakamura, A., & Atsumi, T. (2025). Blood steroid hormone profile and clinical outcomes following switching from metyrapone to osilodrostat in patients with Cushing disease. Endocrine Journal. https://doi.org/10.1507/endocrj.ej25-0089

Vancouver

Yokozeki K, Kameda H, Miya A, Jin S, Matoba K, Nakamura A, et al. Blood steroid hormone profile and clinical outcomes following switching from metyrapone to osilodrostat in patients with Cushing disease. Endocrine Journal. 2025. doi:10.1507/endocrj.ej25-0089

BibTeX
@article{Yokozeki2025,
  author = {Yokozeki, Kei and Kameda, Hiraku and Miya, Aika and Jin, Shigeki and Matoba, Kotaro and Nakamura, Akinobu and Atsumi, Tatsuya},
  title = {Blood steroid hormone profile and clinical outcomes following switching from metyrapone to osilodrostat in patients with Cushing disease},
  journal = {Endocrine Journal},
  year = {2025},
  doi = {10.1507/endocrj.ej25-0089}
}
Kostenlos starten →